Adjuvant therapy for pathologic stage C prostate cancer: A casualty of the PSA revolution?
- 1 February 1996
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 34 (3) , 745-747
- https://doi.org/10.1016/0360-3016(95)02294-5
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Adjuvant radiotherapy for pathologic stage adenocarcinoma of the prostate: Ten-year updateInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Radical prostatectomy for pathologic stage C prostate cancer: Influence of pathologic variables and adjuvant treatment on disease outcomeUrology, 1993
- Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical ProstatectomyJournal of Urology, 1993
- Multivariate analysis of factors predicting local relapse after radical prostatectomy—possible indications for postoperative radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1991
- The Effect of Radiation Therapy after Radical Prostatectomy in Patients with Elevated Prostate Specific Antigen LevelsJournal of Urology, 1990
- Postoperative Radiotherapy for Patients with Carcinoma of the Prostate Undergoing Radical Prostatectomy with Positive Surgical Margins, Seminal Vesicle Involvement and/or Penetration Through the CapsuleJournal of Urology, 1987
- Postoperative radiation therapy for pathologic stage C prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1987
- The role of external beam radiation therapy after prostatectomy for prostate cancerCancer, 1986
- Definitive radiotherapy following prostatectomy: Results and complicationsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Adjuvant Radiotherapy Following Radical Prostatectomy: Results and ComplicationsJournal of Urology, 1986